🔍
Search Results - victor+engelhard
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
MART-1 Phosphopeptides Restricted by HLA-DR1 for use as Melanoma Vaccines
C10691: Novel Peptides as a Melanoma Vaccine Value Proposition: • Phosphopeptides for use as vaccines for therapy and prevention of melanoma • Phosphopeptides for robust, diverse, and long-lasting anti-tumor immunity • Specific activity against whole melanoma tumor cells in vitro • Stand alone therapy/Combination Therapy •...
Published: 3/13/2025
|
Inventor(s):
Donald Hunt
,
Florence Depontieu
,
Angela Zarling
,
Victor Engelhard
,
Jeffrey Shabanowitz
,
Jie Qian
,
Suzanne Topalian
Keywords(s):
Biologics
,
Cancers
,
Disease Indication
,
Immunotherapy
,
Melanoma
,
Peptide
,
Single
,
Skin Cancer
,
Therapeutic Matter
,
Therapeutic Substance
,
Therapeutics
,
Therapy Type
,
Vaccine
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Dermatology
,
Clinical and Disease Specializations > Oncology > Melanoma
,
Clinical and Disease Specializations > Oncology > Skin Cancer
,
Technology Classifications > Therapeutic Modalities > Biologics
,
Technology Classifications > Therapeutic Modalities > Immunotherapies
,
Technology Classifications > Therapeutic Modalities > Peptides
,
Technology Classifications > Therapeutic Modalities > Vaccines
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum